Related content

Effects of risedronate on fracture risk in postmenopausal women with osteopenia

By Siris E.   Simon J.   Barton I.   McClung M.   Grauer A.  

Osteoporosis International, Vol. 19, Iss. 5, 2008-05 ,pp. : 681-686

Springer Publishing Company

Access to resources Recommend Favorite

Prospective Identification of Postmenopausal Osteoporotic Women at High Vertebral Fracture Risk by Radiography, Bone Densitometry, Quantitative Ultrasound, and Laboratory Findings: Results From the PIOS Study

By Glüer Maren Gesina   Minne Helmut W.   Glüer Claus-Christian   Lazarescu A. Doina   Pfeifer Michael   Perschel Frank H.   Fitzner Rudolf   Pollähne Wolfgang   Schlotthauer Tamara   Pospeschill Markus  

Journal of Clinical Densitometry, Vol. 8, Iss. 4, 2005-12 ,pp. : 386-395

Humana Press, Inc

Access to resources Recommend Favorite

Vertebral dimensions as risk factor of vertebral fracture in osteoporotic patients: a systematic literature review

By Ruyssen-Witrand A.   Gossec L.   Kolta S.   Dougados M.   Roux C.  

Osteoporosis International, Vol. 18, Iss. 9, 2007-09 ,pp. : 1271-1278

Springer Publishing Company

Access to resources Recommend Favorite

Vertebral fracture risk (VFR) score for fracture prediction in postmenopausal women

By Lillholm M.   Ghosh A.   Pettersen P.   Bruijne M.   Dam E.   Karsdal M.   Christiansen C.   Genant H.   Nielsen M.  

Osteoporosis International, Vol. 22, Iss. 7, 2011-07 ,pp. : 2119-2128

Springer Publishing Company

Access to resources Recommend Favorite

Adherence to bisphosphonates therapy and hip fracture risk in osteoporotic women

By Rabenda V.   Mertens R.   Fabri V.   Vanoverloop J.   Sumkay F.   Vannecke C.   Deswaef A.   Verpooten G.   Reginster J.-Y.  

Osteoporosis International, Vol. 19, Iss. 6, 2008-06 ,pp. : 811-818

Springer Publishing Company

Access to resources Recommend Favorite